For HBV-related HCC, an adenoviral vector encoding tBid under the control of an AFP-induced promoter, as well as the scFv15-Fdt-HA2-tBid hybrid protein, exhibited remarkable selectivity and induced apoptosis in AFP-positive cells while sparing AFP-negative ones. The gene discussed is BID; the disease is hepatocellular carcinoma.